Pfizer building a brighter future

This week’s announcement of a $100m investment in Pfizer plants in Dublin and Ringaskiddy is a positive move in a sector hit by consolidation and the lapse of patents on big-selling drugs like Viagra and Lipitor, reports Kyran FitzGerald

WHEN you’ve been around almost 45 years, a $30m (€23m) makeover comes in very handy.

Pfizer’s Ringaskiddy plant may be feeling some of the aches and pains of older age. But now, a timely rejuvenation has been promised.